Vortex Therapeutics Inc
Publicly observedLombard, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Lombard | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Vortex Therapeutics Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | QY5RU47AZ7J8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant12 Sept 2025Publicly observed
NIH SBIR/STTR award: Development of a novel MYC inhibitor for cancer therapy
USD 1,142,245.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant12 Sept 2025Publicly observed
NIH SBIR/STTR award: Development of a novel MYC inhibitor for cancer therapy
USD 1,102,729.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.